CYTOGENETIC STUDIES OF BREAST CARCINOMAS - DIFFERENT KARYOTYPIC PROFILES DETECTED BY DIRECT HARVESTING AND SHORT-TERM CULTURE

被引:46
作者
STEINARSDOTTIR, M [1 ]
PETURSDOTTIR, I [1 ]
SNORRADOTTIR, S [1 ]
EYFJORD, JE [1 ]
OGMUNDSDOTTIR, HM [1 ]
机构
[1] ICELANDIC CANC SOC,MOLEC & CELL BIOL RES LAB,REYKJAVIK,ICELAND
关键词
D O I
10.1002/gcc.2870130403
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chromosome analysis was performed on samples from 85 consecutive patients with breast cancer by one or more of three different methods: direct harvest, culture after mechanical disaggregation, and culture after collagenase digestion. Metaphases suitable for karyotyping were obtained in 70% of the cases; direct harvest yielded metaphases in 29% and cultures without and with digestion in 40% and 59%, respectively. Chromosomal abnormalities were detected in 37 cases. Cells judged to be phenotypically abnormal in culture were twice as likely to reveal chromosomal aberrations as normal-looking cells. Eight cases showed multiclonal abnormalities. Significant differences were detected in the karyotypic profile depending on the method used. With direct harvest, the yield of complex chromosomal changes was 87%, compared to 44% after culture of digested tissue (P < 0.01), and also polyploidy was more common in direct-harvested samples. Detailed karyotypic analysis was possible in 29 primary tumors. The chromosomes most frequently involved were 1, 3, 7, 11, 16, and 17. Recurrent structural abnormalities were der(1;16)(q10;p10), i(1)(q10), del(6)(q21), and del(1)(p22). Breakpoints clustered to the centromere regions of chromosomes 1, 3, 11, 15, and 16 and to the short arms of chromosomes 7, 17, and 19. Seven of twenty-nine fully analyzed cases had a family history of breast cancer, and changes of chromosomes 1, 3, and 15 seemed to be more common in these cases. There was an association between karyotype and survival: The 3 year survival was 63% in patients with complex karyotypic changes and 92% in those without complex changes. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:239 / 248
页数:10
相关论文
共 38 条
[1]  
Bardi G, Johansson B, Pandis N, Mandahl N, Bak-Jensen E, Lindstrom C, Tornqvist A, Frederiksen H, Andren-Sandberg A, Mitelman F, Heim S, Cytogenetic analysis of 52 colorectal carcinomas–Nonrandom aberration pattern and correlation with pathologic parameters, Int J Cancer, 55, pp. 422-428, (1993)
[2]  
Bardi G, Johansson B, Pandis N, Mandahl N, Bak-Jensen E, Andren-Sandberg A, Mitelman F, Heim S, Karyotypic abnormalities in tumours of the pancreas, Br J Cancer, 67, pp. 1106-1112, (1993)
[3]  
Bullerdiek J, Leuschner E, Taquia E, Bonk U, Bartnitzke S, Trisomy 8 as a recurrent clonal abnormality in breast cancer?, Cancer Genet Cytogenet, 65, pp. 64-67, (1993)
[4]  
Chen Z, Morgan R, Stone JF, Sandberg AA, FISH: A useful technique in the verification of clonality of random chromosome abnormalities, Cancer Genet Cytogenet, 66, pp. 73-74, (1993)
[5]  
Dal Cin P, Aly MS, Delabie J, Ceuppens JL, Van Gool S, Van Damme B, Baert L, Van Poppel H, Van Den Berghe H, Trisomy 7 and trisomy 10 characterize subpopulations of tumorinfiltrating lymphocytes in kidney tumors and in the surrounding kidney tissue, Proc Natl Acad Sci USA, 89, pp. 9744-9748, (1992)
[6]  
Dutrillaux B, Gerbault-Serueau M, Zafrani B, Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes, Cancer Genet Cytogenet, 49, pp. 203-217, (1990)
[7]  
Eyfjord JE, Thorlacius S, Steinarsdottir M, Valgardsdottir R, Ogmundsdottir HM, Anamathawat-Jonsson K, P53 abnormalities and genomic instability in primary human breast carcinomas, Cancer Res, 55, pp. 646-651, (1995)
[8]  
Ferti-Passantonopoulou A, Panani AD, Raptis S, Preferential involvement of 11q23–24 and 11p15 in breast cancer, Cancer Genetics and Cytogenetics, 51, pp. 183-188, (1991)
[9]  
Fisher CJ, Gillett CE, Vojtesek B, Barnes DM, Millis RR, Problems with p53 immunohistochemical staining: The effect of fixation and variation in the methods of evaluation, British Journal of Cancer, 69, pp. 26-31, (1994)
[10]  
Fuhr JE, Frye A, Kattine AA, Van Meter S, Flow cytometric determination of breast tumor heterogeneity, Cancer, 67, pp. 1401-1405, (1991)